The DOI matches its Crossref record.
Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimers Disease
Abstract
Alzheimers disease (AD) is the most common neurodegenerative disorder that affects the elderly. The increase of lifeexpectancy is transforming AD into a major health-care problem. AD is characterized by a progressive impairment of memory and other cognitive skills leading to dementia. The major pathogenic factor associated to AD seems to be amyloid-beta peptide (Aβ) oligomers that tend to accumulate extracellularly as amyloid deposits and are associated with reactive microglia and astrocytes as well as with degeneration of neuronal processes. The involvement of microglia and astrocytes in the onset and progress of neurodegenerative process in AD is becoming increasingly recognized, albeit it is commonly accepted that neuroinflammation and oxidative stress can have both detrimental and beneficial influences on the neural tissue. However, little is known about the interplay of microglia, astrocytes and neurons in response to Aβ, especially in the early phases of AD. This review discusses current knowledge about the involvement of neuroinflammation in AD pathogenesis, focusing on phenotypic and functional responses of microglia, astrocytes and neurons in this process. The abnormal production by glia cells of pro-inflammatory cytokines, chemokines and the complement system, as well as reactive oxygen and nitrogen species, can disrupt nerve terminals activity causing dysfunction and loss of synapses, which correlates with memory decline; these are phenomena preceding the neuronal death associated with late stages of AD. Thus, therapeutic strategies directed at controlling the activation of microglia and astrocytes and the excessive production of pro-inflammatory and pro-oxidant factors may be valuable to control neurodegeneration in dementia. Keywords: Amyloid-beta, microglia, astrocytes, neurons, pro-inflammatory factors, reactive oxygen species, neurodegeneration, Alzheimer's disease, Dementia, Neuroinflammation, Pro-oxidant factors, Memory, Mild cognitive impairment, CNS, cytokines, prostaglandins, IL-1, PPAR-g, Complement system, Amyloid pla, Trophic factors, Glia-derived neurotrophic factor, Glial scars, Ca2+ overload, Homeostasis, Antioxidants, Electron transport chain, Curcumin, Quercetin
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, they have an impact on the unsaturated fatty acids chain of membrane phospholipids, causing cell lysis [116,117,118].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [117]
In the citing paper
“This immune response causes both an invasion of the glia by circulating immune cells and the production of pro-inflammatory cytokines, tumor necrosis factor (TNF)-α, interleukin (IL) IL-1β and IL-6-, nitric oxide (NO), prostaglandin E2 (PGE2), chemokines, and ROS.”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [117]
In the citing paper
“AD is also induced by neuroinflammation processes that occur as a brain immune barrier [117,154].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [117]
In the citing paper
“Oxidative stress associated with Aβ pathology plays an important role in the death of neurons in the AD brain [82,83,84,85].”
From Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice (2019) · cites this paper as [82]
Citations
Cited by
Sorted by citations
Items 401–500 of 678
Wang, S., Zhang, T., Yang, Z., Lin, J., Cai, B., Ke, Q., Lan, W., Shi, J., Wu, S., & Lin, W. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1329-z · Cited by 17
Kongsui, R., Sriraksa, N., & Thongrong, S. (2020) · BioMed Research International · doi:10.1155/2020/4259316 · Cited by 16
“As neuroinflammation, the activation of astrocytes is stated to be a key factor in the pathophysiology of neurodegeneration [9, 42].”
BackgroundZhang, Z. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.719 · Cited by 17
Guo, Z., Bi, G., Zhang, Y., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104087 · Cited by 16
Casaril, A. M., Domingues, M., Lourenço, D. D. A., Vieira, B. M., Begnini, K. R., Corcini, C. D., França, R. T., Varela, A. S., Seixas, F. K., Collares, T. V., et al. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109278 · Cited by 16
Baker, J. A., Breit, K. R., Bodnar, T. S., Weinberg, J., & Thomas, J. D. (2022) · Nutrients · doi:10.3390/nu14142868 · Cited by 20
“function have been linked to other neurodevelopmental disorders such as schizophrenia [7] and autism spectrum disorders [8], as well as neurodegenerative diseases, including Alzheimer’s disease [9].”
BackgroundModifiable risk factors of dementia linked to excitation-inhibition imbalance
Hafizi, S., & Rajji, T. K. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101804 · Cited by 16
Cong, S., Shi, Y., Yu, G., Zhong, F., Li, J., Liu, J., Ye, C., Tan, Z., & Deng, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115216 · Cited by 15
Ponce-López, T., Tostado, J. A. G. Á., Dias, F., & Maltez, K. H. M. (2023) · Biomolecules · doi:10.3390/biom13091289 · Cited by 16
“Several studies have linked the release of proinflammatory cytokines such as TNF-α, IL-1β, and IL-6 from microglia to the pathogenesis of AD [32].”
BackgroundBrothers, H. M. (2013) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000110 · Cited by 15
“These vulnerable brain regions are likely exposed to a pro-inflammatory environment for many decades [17-19] yet do not show significant pathology until advanced age [12,15,20].”
BackgroundHo, J. Y. S., Poon, D. C.-H., Chan, T. F., & Chang, R. C. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212798919039 · Cited by 16
“Although debate continues on whether senile plaques, NFTs, Lewy bodies or drusen are responsible for the initiation of neurodegeneration in the diseases, large bodies of evidence from cell culture and animal studies show that these aggregated proteins are associated with neuroinflammation, oxidative stress and activat…”
BackgroundGaliana, A., Muñoz-Martínez, V. E., Calero‐Bueno, P., Vela-Romero, M., & Beato‐Fernández, L. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2018.03.004 · Cited by 15
“, 2016), neurological and mental diseases (Agostinho et al., 2010; Bakunina et al., 2015), as well as in other ASD-related disorders Table 1”
BackgroundClark, A. L., Initiative, A. D. N., Weigand, A. J., Thomas, K. R., Solders, S. K., Delano‐Wood, L., Bondi, M. W., Bernier, R. A., Sundermann, E. E., Banks, S. J., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201382 · Cited by 14
Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights
Sanaie, S., Nikanfar, S., Yousefi, Z., Azizi-Zeinalhajlou, A., Sadigh‐Eteghad, S., Araj‐Khodaei, M., Ayati, M. H., & Andalib, S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01059-5 · Cited by 15
Darabi, S., Gorgich, E. A. C., Moradi, F., & Rustamzadeh, A. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.01.004 · Cited by 13
Sayed, N. S. E., Abidar, S., Nhiri, M., Hriţcu, L., & Ibrahim, W. W. (2023) · Phytotherapy Research · doi:10.1002/ptr.7766 · Cited by 18
“2023;37:2437–2453. wileyonlinelibrary.com/journal/ptr © 2023 John Wiley & Sons Ltd. 2437 brain regions (Agostinho et al., 2010; Trejo-Lopez et al., 2022).”
Methyl Jasmonate: Behavioral and Molecular Implications in Neurological Disorders
Aluko, O. M., Iroegbu, J. D., Ijomone, O. M., & Umukoro, S. (2021) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2021.19.2.220 · Cited by 14
Jahed, F. J., Rahbarghazi, R., Shafaei, H., Rezabakhsh, A., & Karimipour, M. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.014 · Cited by 15
Eugenitol ameliorates memory impairments in 5XFAD mice by reducing Aβ plaques and neuroinflammation
Cho, E., Youn, K., Kwon, H., Jeon, J., Cho, W., Park, S. J., Son, S. H., Jang, D. S., Shin, C. Y., Moon, M., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112763 · Cited by 13
Ghosh, S., Debnath, I., Bhunia, S., Nandi, S., Ashique, S., Nayak, A., Mallick, S., & Basak, S. (2025) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2025.09.005 · Cited by 16
Raza, A., Xie, W., Kim, K., Dronamraju, V., Williams, J. L., Vince, R., & More, S. S. (2022) · Antioxidants · doi:10.3390/antiox11061075 · Cited by 13
“There is increasing evidence that oxidative stress and neuroinflammation are contributing factors toward pathogenesis and progression of AD [2,36,37].”
BackgroundOverexpression of fibroblast growth factor 13 ameliorates amyloid-β-induced neuronal damage
Zhu, H., Li, R., Xiao, L., Zhang, T., & Ren, D. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.357902 · Cited by 14
“Thus, oxidative stress is also a recognized mechanism of AD (Agostinho et al., 2010).”
BackgroundHan, C., Zhang, X., Dou, K., Yao, W., Yao, M.-Y., Wan, Q., & Xie, A. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08561-8 · Cited by 13
Atoki, A. V., Aja, P. M., Ondari, E. N., & Shinkafi, T. S. (2023) · International Journal of Food Properties · doi:10.1080/10942912.2023.2243050 · Cited by 20
“[292,293] The glia is invaded by circulating immune cells as a result of this immunological response, and pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α, prostaglandin E2 (PGE 2 ), interleukin (IL) IL-1β and IL-6, ROS, nitric oxide (NO), and chemokines, are also produced.”
BackgroundMa, K.-T., Wu, Y., Yang, Y., Wu, T., Chen, C., Fu, P., Du, J., & Peng, C. Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118117 · Cited by 16
Lee, S. W., Kim, S., Chang, Y., Cha, H., Noeske, R., Choi, C., & Lee, S. J. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.08.018 · Cited by 14
Abou-Taleb, B. A., El-Hadidy, W. F., Masoud, I. M., Matar, N. A., & Hussein, H. S. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124814 · Cited by 14
Park, H., Pang, Q., Kim, Y. S., Kim, J. H., & Cho, E. J. (2021) · Applied Sciences · doi:10.3390/app11052219 · Cited by 13
The Subtelomere of Short Telomeres is Hypermethylated in Alzheimer's Disease.
Guan, J.-Z., Guan, W.-P., Maeda, T., & Makino, N. (2012) · Europe PMC (PubMed Central) · Cited by 14
Lauretti, E., Meco, A. D., Chu, J., & Praticò, D. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.005 · Cited by 13
Nam, Y., Shin, S. J., Park, Y. H., Kim, M., Jeon, S. G., Lee, H., Choi, Y., Kim, T., Shin, S. M., Kim, J.-J., et al. (2021) · Antioxidants · doi:10.3390/antiox10020207 · Cited by 13
“The induced oxidative stress could disrupt neurite terminals and cell bodies, leading to synaptic loss and neuronal cell death [69,70].”
BackgroundLi, X., Ichiba, Y., Watanabe, T., Yoshino, A., Cheng, L., Nagasato, Y., Takata, F., Dohgu, S., Iwasaki, K., Tanaka, M., et al. (2024) · npj Science of Food · doi:10.1038/s41538-024-00360-0 · Cited by 13
Espinosa-Jiménez, T., Cano, A. C., Sánchez‐López, E., Olloquequi, J., Folch, J., Bulló, M., Verdaguer, E., Auladell, C., Pont, C., Muñoz‐Torrero, D., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01000-y · Cited by 13
“Although early in the disease neuroinflammation may represent a protective response, an excessive reaction can cause or contribute to the pathology [88].”
BackgroundXiong, L., Zhang, J., Sun, D., & Liu, H. (2011) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-011-0643-0 · Cited by 13
Yang, B., Han, W., Han, H., Liu, Y., Guan, W., Li, X., & Kuang, H. (2018) · Molecules · doi:10.3390/molecules23040870 · Cited by 12
“Although many hypotheses about the cause of this disease has proven that oxidative damage induced by Aβ toxicity is the main potential mechanism of the disease [5,6].”
BackgroundA Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model
Post, J., Kogel, V., Schaffrath, A., Lohmann, P., Shah, N. J., Langen, K., Willbold, D., Willuweit, A., & Kutzsche, J. (2021) · Molecules · doi:10.3390/molecules26061590 · Cited by 12
Khedher, M. R. B., Haddad, M., Laurin, D., & Ramassamy, C. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12231 · Cited by 12
Promyo, K., Cho, J., Park, K., et al. (2017) · Food Science and Biotechnology · doi:10.1007/s10068-017-0077-3 · Cited by 12
Bui, T. T., & Nguyen, H. T. (2017) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-017-0286-6 · Cited by 11
“IL-10 can regulate Aβ-induced production of the inflammatory cytokines, therefore it may alleviate the risk of AD (Agostinho et al. 2010; Azizi and Mirshafiey 2012).”
BackgroundSemwal, B. C., & Garabadu, D. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1767136 · Cited by 12
Farkhondeh, T., Khan, H. Z., Aschner, M., Samini, F., Pourbagher‐Shahri, A. M., Aramjoo, H., Roshanravan, B., Hoyte, C. O., Mehrpour, O., & Samarghandian, S. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200708130745 · Cited by 12
Shahbazi, S., Zakerali, T., Frycz, B. A., & Kaur, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110895 · Cited by 12
Svirin, E. P., de Munter, J., Umriukhin, A., Sheveleva, E., Kalueff, A. V., Svistunov, A. A., Morozov, S., Walitza, S., & Strekalova, T. V. (2022) · Biomolecules · doi:10.3390/biom12101434 · Cited by 13
“[106], Alzheimer’s disease [77,107], amyotrophic lateral sclerosis [79,108] and myelination”
BackgroundCoffee and its Active Compounds are Neuroprotective
Kim, J., & Lee, K. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-409517-5.00046-2 · Cited by 14
Ferroptosis in Alzheimer’s disease: molecular mechanisms and advances in therapeutic strategies
Zhou, Z., Zhang, Y., Liu, S., Tang, H., Yang, L., Lu, Y., Liao, J., Zhang, S., Chen, Z., & Yang, L. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1673315 · Cited by 17
Arabi, A., Karimi, S. A., Salehi, I., Haddadi, R., & Komaki, A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01191-w · Cited by 12
“2018), treatment strategies aimed at reducing pro-oxidant factor production may be useful in managing neurodegeneration in AD dementia (Agostinho et al. 2010).”
BackgroundVerma, H., Kaur, S., Kaur, S., Gangwar, P., Dhiman, M., & Mantha, A. K. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04053-3 · Cited by 11
Jiang, F., Mao, Y., Liu, H., Xu, P., Zhang, L., Xiaobo, Q., & Sun, X. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1691-1 · Cited by 11
Antioxidants as Potential Therapeutics in Neurodegeneration
Sharma, S. K., & Ebadi, M. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_85 · Cited by 15
Kong, Y., Wu, J., Wang, X., Zhao, J., Song, H., & Yuan, L. (2014) · Genetics and Molecular Research · doi:10.4238/2014.december.4.10 · Cited by 11
Downregulation of Microglial Activation by Achillolide A
Elmann, A., Telerman, A., Mordechay, S., Erlank, H., Rindner, M., Kashman, Y., & Ofir, R. (2015) · Planta Medica · doi:10.1055/s-0034-1396204 · Cited by 12
Mazereeuw, G., Herrmann, N., Xu, H., Figeys, D., OH, P. I., Bennett, S. A. L., & Lanctôt, K. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-119 · Cited by 11
“Recent reviews have implicated aberrant lipid metabolism, inflammatory activity, and oxidative stress as pathophysiological processes involved in cognitive decline [13,14] and these same mechanisms have been associated with depression in CAD [15,16].”
BackgroundEffects of Current Psychotropic Drugs on Inflammation and Immune System
Bhatt, S., Dhar, A. K., Samanta, M. K., & Suttee, A. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_18 · Cited by 12
Insights From TgF344-AD, a Double Transgenic Rat Model in Alzheimer’s Disease Research
Nataraj, A., Blahna, K., & Ježek, K. (2025) · Physiological Research · doi:10.33549/physiolres.935464 · Cited by 10
Mohebichamkhorami, F., Niknam, Z., Khoramjouy, M., Heidarli, E., Ghasemi, R., Hosseinzadeh, S., Mohseni, S. S., Hajikarim‐Hamedani, A., Heidari, A., Ghane, Y., et al. (2022) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-133668 · Cited by 11
Zhao, W., Li, N., Chu, Y., Sun, T., Wang, J., Wang, W., Li, J.-Y., Lin, B., Chen, R., & Hou, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-14062-z · Cited by 10
Curcumin and Inflammatory Brain Diseases
Shehzad, A., Islam, S. U., & Lee, Y. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00024-4 · Cited by 11
Vahid, Z. F., Eskandani, M., Dadashi, H., Vandghanooni, S., & Rashidi, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40756 · Cited by 14
Zarneshan, S. N., Arkan, E., Kiani, A., Hosseini, S. Z., Abbaszadeh, F., & Fakhri, S. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03696-2 · Cited by 12
Novel Soluble Epoxide Hydrolase Inhibitor: Toward Regulatory Preclinical Studies
Jarné‐Ferrer, J., Sánchez, J., Codony, S., Schneider, M., Müller, C. E., Sanfeliu, C., Franco, R., Vázquez, S., Griñán‐Ferré, C., & Pallàs, M. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00629 · Cited by 10
Mohammed, V., Arasu, M. V., Muthuramamoorthy, M., Namasivayam, S. K. R., & Arockiaraj, J. (2025) · Toxicology Letters · doi:10.1016/j.toxlet.2025.06.022 · Cited by 9
Kwon, M.-J., Lee, J.-W., Kim, K., Chen, H., Cui, C., Lee, G. W., & Cho, Y. H. (2022) · Molecules · doi:10.3390/molecules27144455 · Cited by 8
“Memory impairment is known to be caused by severe damage to the cholinergic system, which is related to various dysfunctions in memory, learning, language, administrative function, social cognition, and motor ability [1,2].”
BackgroundYamaguchi, H., Kawahara, H., Kodera, N., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.839917 · Cited by 9
“The extracellular deposition of amyloid leads to destruction of normal tissue structure and cellular dysfunction (Agostinho et al., 2010; Merlini et al., 2011).”
BackgroundPenicillospirone from a marine isolate of Penicillium sp. (SF-5292) with anti-inflammatory activity
Lee, S.-J., Kim, D., Park, J.-S., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.05.066 · Cited by 9
Magnetic Resonance Spectroscopy
Merugumala, S. K., Ramadan, S., Keenan, W., Liao, H. V., Wang, L. Y.-J., & Lin, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-54542-9_6 · Cited by 9
Doumar, H., Mostafi, H. E., Elhessni, A., Abderrahim, L., & Mesfioui, A. (2024) · Pathophysiology · doi:10.3390/pathophysiology31040047 · Cited by 8
Svobodová, B., Moravcová, Z., Misiachna, A., Nováková, G., Marek, A., Finger, V., Odvarkova, J., Pejchal, J., Karasová, J. Ž., Netolický, J., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117678 · Cited by 10
Kim, D., Park, J., Yoon, C., Kim, Y., & Oh, H. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11720 · Cited by 8
Ameliorative effect of carveol on scopolamine-induced memory impairment in rats.
Latif, K., Saneela, S., & Khan, A. (2022) · PubMed Central · doi:10.22038/ijbms.2022.66797.14647 · Cited by 8
“Oxidative stress causes high oxygen consumption in the central nervous system, which contributes to AD pathogenesis (41, 42).”
BackgroundAngarita-Rodríguez, A., González‐Giraldo, Y., Rubio-Mesa, J. J., Aristizábal-Pachón, A. F., Pinzón, A. M., & González, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010365 · Cited by 8
Yang, A., Yi, X., Zhang, H., Shen, R., & Kou, X. (2024) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14529 · Cited by 7
“The amyloid cascade hypothesis suggested that the aggregation of A β peptides was a central event of AD (Agostinho et al., 2010).”
BackgroundSinha, M. S., Behera, P., Bhowmick, P., Banerjee, K., Basu, S., & Chakrabarti, S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110686 · Cited by 8
“Apart from the crucial role of A 42 oligomers and protofibrils in AD pathogenesis, oxidative stress, mitochondrial dysfunction, inflammatory reactions, and various epigenetic mechanisms and environmental factors also contribute to the latter process, but the precise relationship among these different mechanisms is not…”
Han, J. Z., Yin, Q., Yang, F., Shou, W., Zhang, C., & Guo, F. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9055 · Cited by 8
“Previous studies have demonstrated that neuroinflammation induced by microglia is implicated in the pathogenesis of AD (37,38).”
Adenosine Receptors in Alzheimer’s Disease
Canas, P. M., Cunha, R. A., & Agostinho, P. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-90808-3_11 · Cited by 8
Self-citationKim, J. H., He, M. T., Kim, M. J., Park, C. H., Lee, J. Y., Shin, Y. S., & Cho, E. J. (2020) · Korean Journal of Medicinal Crop Science · doi:10.7783/kjmcs.2020.28.2.85 · Cited by 8
Simhadri, P. K., & Babu, P. P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02598-1 · Cited by 7
Zheng, Y., Xu, Q., Jin, Q., Du, Y., Yan, J., Gao, H., & Zheng, H. X. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.03.048 · Cited by 9
Nopparat, C., Boontor, A., Panmanee, J., & Govitrapong, P. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00522-6 · Cited by 8
“Regarding the pathogenesis of AD, the amyloid cascade hypothesis is the most preferable hypothesis because Aβ peptide deposition is considered an early event in AD pathogenesis (Agostinho et al. 2010).”
BackgroundLi, Y., Li, G.-H., Sun, L., Li, L., Liu, Y., Kong, D., Wang, S., Ren, D., Wang, X., Lou, H., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7616852 · Cited by 8
Pollen, D. A., Baker, S. P., Hinerfeld, D. A., Swearer, J. M., Evans, B. A., Evans, J. E., Caselli, R. J., Rogaeva, E. A., George‐Hyslop, P. S., & Moonis, M. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt55 · Cited by 7
Youn, J.-E., Kwon, Y., Lee, Y.-J., Heo, S., & Lee, J. (2025) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2025.100564 · Cited by 9
“Inflammation triggered by poor dietary choices can affect the brain through this pathway, leading to neuroinflammation and reactive oxygen species generation, disrupting synaptic function and contributing to cognitive decline, particularly memory impairment [44,45].”
Majid, H., Dahalia, M., Hussain, S., Saini, S., & Nidhi, N. (2025) · Diabetology International · doi:10.1007/s13340-025-00830-0 · Cited by 7
“This shift, processing up to 30% of glucose in pathological states, leads to sorbitol accumulation and tissue damage, contributing to diabetic complications such as neuropathy and retinopathy [78, 79].”
Prabha, S., Choudhury, A., Jawaid, T., Saeed, M. U., Thakur, S. C., & Hassan, M. I. (2025) · 3 Biotech · doi:10.1007/s13205-025-04413-3 · Cited by 8
Vashisht, K., Kumar, H., Ankalgi, A. D., Ashawat, M. S., Rimpi, Kushawaha, S. K., & Baldi, A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01869-w · Cited by 7
“By concurrently modulating inflammation (NF-κB inhibition), oxidative stress (Nrf2/HO-1 activation), and tau pathology (Wnt3α/β-catenin signaling enhancement), ASP strategically intervenes at three critical pathological junc-tures in AD (Agostinho et al. 2010).”
Preethy, H. A., Rajendran, K., Mishra, A., Karthikeyan, A., Chellappan, D. R., Ramakrishnan, V., & Krishnan, U. M. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104999 · Cited by 7
Fraile-Ramos, J., Reig, J., & Giménez‐Llort, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116112 · Cited by 8
“New approaches have also considered additional alterations involved in this disease, such as oxidative stress, reactive glia, and changes in microglia, as important factors involved in the generation and progression of this disease [1].”
BackgroundGrifola frondosa polysaccharides alleviate Alzheimer's disease in rats
Behrad, S., Pourranjbar, S., Pourranjbar, M., Abbasi-Maleki, S., Mehr, S. R., Salmani, R. H. G., & Moradikor, N. (2024) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/apjtb.apjtb_294_24 · Cited by 7
Lazarova, M. I., Stefanova, M. O., Tsvetanova, E. R., Georgieva, A. P., Tasheva, K. N., Radeva, L., & Yoncheva, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312777 · Cited by 8
Liu, H., Kuo, Y., Cheng, J., Chang, L.-Z., Chang, M.-S., Su, L., Chuang, T.-N., & Lin, W. (2021) · Molecules · doi:10.3390/molecules26175338 · Cited by 7
“Elevated ROS may, in turn, trigger cytokine release and initiate inflammation [7,9,10].”
BackgroundDik, B., Coşkun, D., Bahçıvan, E., & Er, A. (2019) · PubMed · Cited by 7
Berntsson, E., Paul, S., Vosough, F., Sholts, S. B., Jarvet, J., Roos, P. M., Barth, A., Gräslund, A., & Wärmländer, S. K. T. S. (2021) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5493 · Cited by 7
Zhang, W., Jin, T., & Hu, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1521850 · Cited by 6
Firdoos, S., Dai, R., Tahir, R. A., Khan, Z. Y., Li, H., Zhang, J., Ni, J., Quan, Z., & Qing, H. (2023) · Journal of Molecular Modeling · doi:10.1007/s00894-023-05609-1 · Cited by 6
Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease
Siokas, V., Stamati, P., Pateraki, G., Liampas, I., Aloizou, A., Tsirelis, D., Νούσια, Α., Sgantzos, M. N., Nasios, G., Bogdanos, D. P., et al. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100302 · Cited by 7
“The human brain is extremely sensitive to oxidative stress due to its elevated rate of oxygen metabolic activity, high levels of polyunsaturated fatty acids, a very oxidizable substrate, and low amounts of antioxidant systems compared to other organs [18,19].”
BackgroundHong, J. Y., Ban, J., Quan, Q.-L., Eom, J.-E., Shin, H. S., & Chung, J. H. (2022) · Foods · doi:10.3390/foods11213418 · Cited by 6
Kou, X., Shi, X., Pang, Z., Yang, A., Shen, R., & Zhao, L. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230125153027 · Cited by 6
Minné, D., Stromin, J., Docrat, T. F., Engel-Hills, P. C., & Marnewick, J. L. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.06.008 · Cited by 7
Wang, Z., Shan, W., Cao, J., et al. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24186 · Cited by 6
Amla Therapy as a Potential Modulator of Alzheimer’s Disease Risk Factors and Physiological Change
Teimouri, E., Rainey‐Smith, S. R., Bharadwaj, P., Verdile, G., & Martins, R. N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191033 · Cited by 6
Yaacob, W. M. H. W., Long, I., Zakaria, R., & Othman, Z. (2020) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-020-00449-3 · Cited by 5
“Uncontrolled inflammation and excessive free radical production will trigger neurodegeneration and cell death cascades (Agostinho et al. 2010).”
Background
Metadata
- Authors
- Agostinho, P., A. Cunha, R., & Oliveira, C.
- Affiliations
- University of Coimbra (PT)
- Corresponding author
- Oliveira, Catarina
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-08-01
- Volume
- 16
- Issue
- 25
- Pages
- 2766-2778
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2114324710
- Cited by
- 685
- References
- 0
- Citations by year
- 2026: 35 · 2025: 44 · 2024: 46 · 2023: 43 · 2022: 52 · 2021: 61 · 2020: 58 · 2019: 42 · 2018: 44 · 2017: 51 · 2016: 32 · 2015: 36 · 2014: 34 · 2013: 37 · 2012: 41
- FWCI
- 20.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Pharmaceutical Design (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, neuroinflammation, oxidative stress, amyloid-beta oligomers, amyloid plaques, microglia, astrocytes, neurodegeneration, inflammatory cytokines, chemokines, complement system, reactive oxygen species, reactive nitrogen species, synaptic loss, memory impairment, mild cognitive impairment, glial activation, antioxidants, curcumin, quercetin, glial scar, calcium overload, PPARγ
- MeSH terms
- Alzheimer Disease, Animals, Antioxidants, Brain, Humans, Models, Neurological, Nerve Degeneration, Neuroglia, Drug Delivery Systems, Oxidative Stress, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review